Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

503 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Japan Society of Obstetrics and Gynecology revised diagnostic criteria for polycystic ovary syndrome: JSOG2024 criteria.
Noguchi H, Iwase A, Iwasa T, Kanasaki H, Kimura F, Kugu K, Saito K, Baba T, Hara T, Minato S, Yanagihara R, Matsuzaki T; from the subcommittee “Validation of diagnostic criteria for polycystic ovary syndrome in Japan” in Reproductive Endocrine Committee, Japan Society of Obstetrics and Gynecology. Noguchi H, et al. Among authors: iwasa t. J Obstet Gynaecol Res. 2024 Nov 21. doi: 10.1111/jog.16152. Online ahead of print. J Obstet Gynaecol Res. 2024. PMID: 39569644
Comparison of endogenous hypothalamic and serum OT levels between young and middle-aged perimenopausal female rats.
Masaki R, Yamamoto Y, Tamura K, Aoki H, Noguchi H, Takeda A, Minato S, Tanano R, Yamanaka E, Maeda T, Sugimoto T, Sasada H, Inui H, Kagawa T, Yoshida A, Mineda A, Kinouchi R, Yoshida K, Kaji T, Iwasa T. Masaki R, et al. Among authors: iwasa t. J Med Invest. 2024;71(3.4):246-250. doi: 10.2152/jmi.71.246. J Med Invest. 2024. PMID: 39462559 Free article.
A randomized, double-blind, placebo-controlled phase II study of olanzapine-based prophylactic antiemetic therapy for delayed and persistent nausea and vomiting in patients with HER2-positive or HER2-low breast cancer treated with trastuzumab deruxtecan: ERICA study (WJOG14320B).
Sakai H, Tsurutani J, Ozaki Y, Ishiguro H, Nozawa K, Yamanaka T, Aogi K, Matsumoto K, Iwasa T, Tokiwa M, Tsuneizumi M, Miyoshi Y, Kitagawa C, Yamamoto M, Takano Y, Imamura CK, Chiba Y, Takiguchi D, Ezumi T, Takano T. Sakai H, et al. Among authors: iwasa t. Ann Oncol. 2024 Sep 14:S0923-7534(24)03995-4. doi: 10.1016/j.annonc.2024.09.001. Online ahead of print. Ann Oncol. 2024. PMID: 39284382 Free article.
503 results